HC Wainwright & Co. Downgrades CytoSorbents to Neutral, Lowers Price Target to $1
HC Wainwright & Co. Downgrades CytoSorbents to Neutral, Lowers Price Target to $1
HC Wainwright & Co.將CytoSorbents的評級下調至中性,將目標股價下調至1美元
HC Wainwright & Co. analyst Sean Lee downgrades CytoSorbents (NASDAQ:CTSO) from Buy to Neutral and lowers the price target from $5.5 to $1.
HC Wainwright & Co. 分析師肖恩·李將CytoSorbents(納斯達克股票代碼:CTSO)的評級從買入下調至中性,並將目標股價從5.5美元下調至1美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。